Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...
Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...
It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...
Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...
A new Cedars Sinai Physician Associated Study used the processes and care of Daybreak to evaluate a dentist-led, ...
The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...
NEW BERN, N.C. (WNCT) — A medical team with the CarolinaEast Health System are offering a new solution for those who struggle with a CPAP machine. Medical personnel with the Ear, Nose and Throat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results